terine fibroids: Impact of ulipristal acetate 10 mg on ART results. - ulipristal acetate 10 mg and Asisted Reproduction

IVI Valencia0 个研究点目标入组 2 人开始时间: 2014年7月4日最近更新: 2022年4月19日

适应症

试验速览

暂无简介。

•Patients> 18 and <50 years
•Patients who undergo a first / second cycle OVD
•Patients who present within 1-3 intramural myomas> 2 cm and <5 cm that do not distort the cavity, Type 3 and 4 of the FIGO classification (Figure 1).
•Miomas inoperable for medical judgment or patient desire, you want to avoid the post-surgical time waiting 6 months / 1 year before you can submit to TRA
•Patients who have undergone previous myomectomy who prefer to avoid having surgery again
•BMI 18-30 kg/m2
•Informed consent signed and dated
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 282
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•History of endometrial changes in patients (hyperplasia)
•Presence of other endometrial pathologies: polyps, scars of previous cesarean complicated adenomyosis foci, suspected adhesions
•Simultaneous participation in another clinical study

发起方

IVI Valencia